| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| botulinum toxin type b | synaptotagmin-2 | biotech | NA | drugbank , DGIDB | Neck Pain[MeSHID:D019547] Cervical Dystonia[MeSHID:D014103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Parkinson Disease[MeSHID:D010300] |
NA | approved,investigational | unknown |
| botulinum toxin type b | vesicle-associated membrane protein 1 | biotech | NA | drugbank , DGIDB | Neck Pain[MeSHID:D019547] Cervical Dystonia[MeSHID:D014103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Parkinson Disease[MeSHID:D010300] |
NA | approved,investigational | binder |
| botulinum toxin type b | vesicle-associated membrane protein 2 | biotech | NA | drugbank , DGIDB | Neck Pain[MeSHID:D019547] Cervical Dystonia[MeSHID:D014103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Parkinson Disease[MeSHID:D010300] |
31.83 | approved,investigational | binder,inhibitor |
| botulinum toxin type b | vesicle-associated membrane protein 2 | biotech | NA | drugbank , DGIDB | Neck Pain[MeSHID:D019547] Cervical Dystonia[MeSHID:D014103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Parkinson Disease[MeSHID:D010300] |
NA | approved,investigational | binder |
| click here to return to the previous page | ||||||||